NDC 69238-1657

Tavaborole

Tavaborole

Tavaborole is a Topical Solution in the Human Prescription Drug category. It is labeled and distributed by Amneal Pharmaceuticals Ny Llc. The primary component is Tavaborole.

Product ID69238-1657_3a89e994-c11b-4867-a1a0-a4e97767fe2c
NDC69238-1657
Product TypeHuman Prescription Drug
Proprietary NameTavaborole
Generic NameTavaborole
Dosage FormSolution
Route of AdministrationTOPICAL
Marketing Start Date2020-11-28
Marketing CategoryANDA / ANDA
Application NumberANDA212256
Labeler NameAmneal Pharmaceuticals NY LLC
Substance NameTAVABOROLE
Active Ingredient Strength44 mg/mL
Pharm ClassesOxaborole Antifungal [EPC],Protein Synthesis Inhibitors [MoA],Boron Compounds [CS]
NDC Exclude FlagN
Listing Certified Through2021-12-31

Packaging

NDC 69238-1657-4

1 BOTTLE, WITH APPLICATOR in 1 CARTON (69238-1657-4) > 4 mL in 1 BOTTLE, WITH APPLICATOR
Marketing Start Date2020-11-28
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "Tavaborole" or generic name "Tavaborole"

NDCBrand NameGeneric Name
0574-0157TavaboroleTavaborole
21922-020TavaboroleTAVABOROLE topical solution, 5%
51672-1397TAVABOROLETAVABOROLE
51862-690tavaboroletavaborole
62332-467TavaboroleTavaborole
63629-8704TavaboroleTavaborole
68180-958TavaboroleTavaborole
69097-686TAVABOROLETAVABOROLE
69238-1657TavaboroleTavaborole
71589-010TAVABOROLETAVABOROLE
72763-201TavaboroleTavaborole
10337-905KerydinTavaborole

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.